سعر تولتيرودين Tolterodine‏ 2 مجم 30قرص 2026

Tolterodine L-tartrate 2 mg film-coated tablets (Sabaa/Activa Therapeutics, Egypt), antimuscarinic for overactive bladder; pack of 30.

• Most common: dry mouth (most frequent), headache, constipation, vertigo/dizziness and abdominal pain; other expected antimuscarinic effects include abnormal vision, urinary retention and dry eyes.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Urinary retention, gastric retention or uncontrolled narrow-angle glaucoma; hypersensitivity to tolterodine, its ingredients or to fesoterodine fumarate (both metabolised to 5-hydroxymethyl tolterodine).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Anaphylaxis and angioedema requiring hospitalisation have occurred with the first or subsequent doses; discontinue if breathing difficulty, airway obstruction or hypotension occurs.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Potent CYP3A4 inhibitorsReduce tolterodine dose to 1 mg twice daily with potent CYP3A4 inhibitors.DailyMed (U.S. National Library of Medicine)

• No studies in pregnant women; embryolethality and fetal abnormalities in mice at high doses; use in pregnancy only if benefit justifies the potential fetal risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Excreted in mouse milk; human milk excretion unknown; tolterodine should not be administered during nursing.International label, same formulation · DailyMed (U.S. National Library of Medicine)